Kelyniam Global, a leading maker of custom cranial implants, recently announced its financial results for the year ended December 31, 2023. Despite a 12% decrease in total revenue compared to the previous year, the company achieved a quarterly unit sales record in the fourth quarter. This success was attributed to strategic investments made earlier in the year, which set the stage for growth.
Key financial highlights for the year included total revenue of $2,672,357, operating income of -$239,166, and a net income of -$218,471. While these numbers reflect a decrease from the previous year, the company saw a significant improvement in unit and revenue growth in the fourth quarter, with a 40% increase over the previous quarter.
Events that impacted the year and fourth quarter included a major competitor pulling their implant from the market, creating an opportunity for Kelyniam to increase sales of their PEEK and CustomizedBoneä implants. The company also added 5 new sales representatives as distributor partners, further expanding its reach in the market.
Looking ahead, Kelyniam is well-positioned to capitalize on the loss of its competitor and solidify its position as a leader in regenerative options for U.S. surgeons. With a focus on custom prosthetics using advanced medical grade polymers, the company aims to improve clinical outcomes and cost-of-care for patients.
As investors consider the company’s prospects, it’s important to note that certain matters discussed in this press release are forward-looking statements. These statements involve risks and uncertainties that could impact actual results, including changes in economic conditions, competitive factors, and the company’s ability to execute its sales plans.
For more information on Kelyniam Global and its financial performance, visit the company’s website at http://www.Kelyniam.com. Stay informed about the latest developments and advancements in custom cranial and maxillo-facial implants by following Kelyniam on their website.
Source: Kelyniam Global Inc.
Source link
